| Identification | Back Directory | [Name]
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide | [CAS]
1675248-19-7 | [Synonyms]
Tofacitinib-24
Tofacitinib Imp.Q
Tofacitinib Impurity JJ
Tofacitinib Related Compound 7
Tofacitinib Citrate Impurity 05
1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
Tofacitinib Imp.Q :3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
Tofacitinib impurity 18/3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide | [Molecular Formula]
C16H22N6O2 | [MDL Number]
MFCD26967966 | [MOL File]
1675248-19-7.mol | [Molecular Weight]
330.39 |
| Chemical Properties | Back Directory | [storage temp. ]
Storage temp. 2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
Off-White to Pale Orange | [InChI]
InChI=1/C16H22N6O2/c1-10-4-6-22(14(24)7-13(17)23)8-12(10)21(2)16-11-3-5-18-15(11)19-9-20-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H2,17,23)(H,18,19,20)/t10-,12+/s3 | [InChIKey]
CRDMXSMPTHMXRD-OMRPPZTANA-N | [SMILES]
N([C@@H]1[C@@H](CCN(C(=O)CC(=O)N)C1)C)(C1N=CN=C2NC=CC=12)C |&1:1,2,r| |
| Hazard Information | Back Directory | [Uses]
Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. |
|
| Company Name: |
Roark Standards
|
| Telephone: |
0755-83552066 15986688328 |
| Website: |
roarkstandards.com |
|